- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Angiomyolipoma.
Displaying page 1 of 1.
EudraCT Number: 2012-005397-63 | Sponsor Protocol Number: CRAD001MES12 | Start Date*: 2013-04-19 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A, | |||||||||||||
Full Title: An open-label, multi-center, expanded access study of RAD001 in patients with angiomyolipoma associated with tuberous sclerosis complex (TSC) | |||||||||||||
Medical condition: Angiomyolipoma associated with either Tuberous Sclerosis Complex (TSC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002113-48 | Sponsor Protocol Number: CRAD001M2302 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) | |||||||||||||
Medical condition: Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) NL (Completed) GB (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003745-32 | Sponsor Protocol Number: 7061 | Start Date*: 2008-12-12 | ||||||||||||||||
Sponsor Name:University of Nottingham | ||||||||||||||||||
Full Title: A randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. | ||||||||||||||||||
Medical condition: Lymphangioleiomyomatosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-004919-20 | Sponsor Protocol Number: StudioLAM | Start Date*: 2016-03-09 | |||||||||||
Sponsor Name:MULTIMEDICA S.P.A. | |||||||||||||
Full Title: A pilot study of nintedanib for lymphangioleiomyomatosis (LAM) | |||||||||||||
Medical condition: Female subjects affected by Llymphangioleiomyomatosis (LAM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019825-32 | Sponsor Protocol Number: CRAD001X2201 | Start Date*: 2010-07-28 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerability, PK and efficacy trial of RAD001 (everolimus) in patients with Lymphangioleiomyomatosis. | |||||||||||||
Medical condition: Lymphangioleiomyomatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001884-39 | Sponsor Protocol Number: CBEZ235ZIC01 | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A phase II study of orally administered BEZ235 monotherapy in patients with metastatic or unresectable malignant PEComa | |||||||||||||
Medical condition: Adult patient with metastatic or unresectable malignant perivascular epithelioid cell tumors (PEComa) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005978-30 | Sponsor Protocol Number: FP2007/02 | Start Date*: 2008-01-22 | |||||||||||
Sponsor Name:FUNDACIÓ PUIGVERT | |||||||||||||
Full Title: Ensayo clínico para evaluar la eficacia y seguridad de la rapamicina en los angiomiolipomas en pacientes con esclerosis tuberosa Clinical Trial to Determine the Efficacy and Safety of Rapamycin in ... | |||||||||||||
Medical condition: Angiomiolipomas en pacientes con esclerosis tuberosa (angiomyolipoma of tuberous sclerosis patients) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.